Invokana Risks

Invokana Kidney Failure Warning

Janssen_INVOKANA-300Omrani & Taub are actively reviewing potential compensation claims for people who suffered kidney failure, myocardial infarction (heart attacks), other cardiovascular issues and ketoacidosis after using the diabetes drug Invokana.

In March 2013, Invokana (canagliflozin) was introduced by Johnson & Johnson, and has rapidly grown to become a blockbuster treatment for type 2 diabetes from aggressive advertising and marketing of this drug. However, it now appears that the drug maker may have withheld important information about the potential risks users may face of side effects from Invokana.

CLICK HERE FOR A FREE CONSULTATION

Possible financial compensation may be available for individuals who have suffered:

  • Kidney Failure
  • Heart Attack
  • Stroke
  • Diabetic Ketoacidosis
  • Wrongful Death

To review whether you, a friend or family member may be eligible to pursue an Invokana injury claim call 212-LAW SUIT for a free consultation and case evaluation, or fill this form. Because strict time deadlines apply to filing a claim, we recommend contacting us at your earliest convenience. There are no up-front fees and because we represent clients on a contingency basis, there are no fees until you win your case

case-results

$10,581,576

For 11-year-old girl struck by van

$6,000,000

For passenger injured in NYC bus accident

$4,450,000

Recovered for undocumented construction worker

$3,900,000

For father struck by falling stop sign

$3,000,000

For driver injured in bus accident

$3,000,000

Supermarket slip and fall

$2,000,000

For driver who lost control of vehicle as a result of dangerous roadway

$1,900,000

For passenger injured in two-car collision

$1,500,000

For student who tripped and fell in fire drill

*past results do not guarantee future outcomes.

Omrani and Taub case results